Dig Favce Sirum

Exosome precipitation from Plasma and Serum
EPStep-PS 5 ml
EUR 356.4

Dog Serum Laboratories manufactures the dig favce sirum reagents distributed by Genprice. The Dig Favce Sirum reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Dog Serum. Other Dig products are available in stock. Specificity: Dig Category: Favce Group: Sirum

True north Cryobox1.5/2mLNatural
PK10
EUR 162

True north Cryobox1.5/2.0mLGreen
PK10
EUR 162

Exosome precipitation from Plasma and Serum
5 ml
EUR 356.4

Blood and Serum DNA Isolation Kit
1 kit
EUR 355

True north Cryobox 1.5/2.0mLBlue
PK10
EUR 100.8

True north Cryobox 1.5/2.0mLBlue
PK10
EUR 162

True north Cryobox 1.5/2mLPurple
PK10
EUR 162

Sirum information

Anti-Dig. Coated Mag. Particles
DIGMS-20-2 2 mL
EUR 372
Description: Please reffer to the technical data sheet for more detail information for this item. Our dedicated team would be happy to assist you via live chat, email or phone.

Anti-Dig. Coated Mag. Particles
DIGMS-40-2 2 mL
EUR 372
Description: Please reffer to the technical data sheet for more detail information for this item. Our dedicated team would be happy to assist you via live chat, email or phone.

Anti-IL6 (Sirukumab)-MC-MMAF ADC
ADC-W-1408 1mg Ask for price
Description: This ADC product is comprised of an anti-IL6 monoclonal antibody conjugated via a MC linker to MMAF

Anti-IL6 (Sirukumab)-SMCC-DM1 ADC
ADC-W-1406 1mg Ask for price
Description: This ADC product is comprised of an anti-IL6 monoclonal antibody conjugated via a SMCC linker to DM1

Anti-IL6 (Sirukumab)-SPDB-DM4 ADC
ADC-W-1407 1mg Ask for price
Description: This ADC product is comprised of an anti-IL6 monoclonal antibody conjugated via a SPDB linker to DM4

Anti-IL6 (Sirukumab)-MC-Vc-PAB-MMAE ADC
ADC-W-1409 1mg Ask for price
Description: This ADC product is comprised of an anti-IL6 monoclonal antibody conjugated via a MC-Vc linker to MMAE

Anti-IL6 (Sirukumab)-MC-Vc-PAB-SN38 ADC
ADC-W-1410 1mg Ask for price
Description: This ADC product is comprised of an anti-IL6 monoclonal antibody conjugated via a MC-Vc-PAB linker to SN38

Anti-IL6 (Sirukumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC
ADC-W-1411 1mg Ask for price
Description: This ADC product is comprised of an anti-IL6 monoclonal antibody conjugated via a MC-Vc-PAB-DMEA-(PEG2) linker to duocarmycin SA

Recombinant FrAdV-1 FaV1gp13 Protein (aa 1-204)
VAng-Cr4195-1mgEcoli 1 mg (E. coli)
EUR 4200
Description: FrAdV-1 (strain ATCC VR-896) Adenain (FaV1gp13), recombinant protein.

Recombinant FrAdV-1 FaV1gp13 Protein (aa 1-204)
VAng-Cr4195-500gEcoli 500 µg (E. coli)
EUR 2997.6
Description: FrAdV-1 (strain ATCC VR-896) Adenain (FaV1gp13), recombinant protein.

Recombinant FrAdV-1 FaV1gp13 Protein (aa 1-204)
VAng-Cr4195-50gEcoli 50 µg (E. coli)
EUR 2040
Description: FrAdV-1 (strain ATCC VR-896) Adenain (FaV1gp13), recombinant protein.

Favipiravir
10-027 100 mg
EUR 440.88
Description: The guanine analog Favipiravir is a broad spectrum inhibitor of viral RNA polymerase, acting on viral genetic copying to prevent its reproduction. Favipiravir is a prodrug that is metabolized to its active form, favipiravir-ribofuranosyl-5'-triphosphate (Favipiravir-RTP), which inhibits selectively RNA-dependent RNA polymerase (RdRp) in RNA viruses. This antiviral agent inhibits influenza A, B and C without inducing cytotoxicity up to 1,000 µg/ml. It also inhibits influenza strains resistant to current antiviral drugs and shows a synergistic effect in combination with oseltamivir (Prod. No. AG-CR1-3714), thereby expanding influenza treatment options. Favipiravir is active against a variety of additional viruses, including West Nile virus, yellow fever virus, foot-and-mouth disease virus as well as other flaviviruses, arenaviruses, bunyaviruses and alphaviruses in vitro and in vivo. Activity has also been shown against enteroviruses, Rift Valley fever virus and Marburg virus (MARV9), while limited efficacy has been shown against Ebola virus (EBOV) and Zika virus in animal studies. Favipiravir shows potential efficacy against SARS-CoV-2 and is undergoing clinical studies to test its efficacy and safety in the treatment of coronavirus disease 2019 (COVID-19).

Favipiravir
HY-14768 10mg
EUR 157.2

T-705 (Favipiravir)
2778-25 each
EUR 692.4

T-705 (Favipiravir)
2778-5 each
EUR 222

Favorgen RNase Destroyer Sprayer
FARND-001 2 x sprayer & 1x sprayer head
EUR 201.6
Description:
  • For solid waste
  • Contains 2 x sprayer & 1x sprayer head/pack

Favorgen RNase Destroyer Sprayer
FARND-001-1 1 bottle/ 1L
EUR 255.6
Description:
  • Sprayer Supplement-1 bottle/ 1L
  • Package: 1 bottle in a retail box